Table 1.

Baseline characteristics of participants

Clinical CharacteristicControlCKDHDTotalP
n19 (7%)145 (52%)116 (41%)280 (100%)
Gender17 (89%)141 (97%)73 (63%)231 (83%)<0.0001
Race<0.0001
    white15 (79%)121 (83%)15 (13%)151 (54%)
    black3 (16%)16 (11%)99 (85%)118 (42%)
    other1 (5%)8 (6%)2 (2%)11 (4%)
Age (years)60.1 ± 10.069.0 ± 10.651.5 ± 11.461.1 ± 13.7<0.0001
Height (cm)178.3 ± 6.9174.3 ± 8.6172.1 ± 10.1173.8 ± 9.20.02
Weight (kg)87.7 ± 15.293.2 ± 16.881.7 ± 19.288.3 ± 18.4<0.0001
Body mass index (kg/m2)27.5 ± 4.030.6 ± 4.727.5 ± 6.029.2 ± 5.4<0.0001
Cardiovascular disease0 (0%)83 (57%)28 (24%)111 (40%)<0.0001
Diabetes mellitus0 (0%)86 (59%)46 (40%)132 (47%)<0.0001
Albumin (g/dl)4.0 ± 0.33.7 ± 0.43.6 ± 0.53.7 ± 0.4<0.01
Hemoglobin (g/dl)14.7 ± 0.913.2 ± 1.712.0 ± 1.412.8 ± 1.7<0.0001
eGFR (ml/min per 1.73 m2)77.6 ± 7.943.9 ± 14.3NA47.8 ± 17.4<0.0001
  • HD, hemodialysis.